Perritt Capital Management’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History

Perritt Capital Management’s Portfolio OPNT Stock Details OPNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-30,500	Closed	-$328K	–	310
2022 Q3	$328K	Hold	30,500	–	–	0.21%	113
2022 Q2	$366K	Hold	30,500	–	–	0.22%	115
2022 Q1	$653K	Sell	30,500 -1,500	-5%	-$39.7K	0.35%	80
2021 Q4	$1.08M	Hold	32,000	–	–	0.56%	37
2021 Q3	$824K	Hold	32,000	–	–	0.45%	58
2021 Q2	$428K	Hold	32,000	–	–	0.22%	125
2021 Q1	$340K	Hold	32,000	–	–	0.19%	140
2020 Q4	$257K	Buy	32,000 +2,500	+8%	+$19.7K	0.16%	151
2020 Q3	$221K	Hold	29,500	–	–	0.16%	141
2020 Q2	$266K	Sell	29,500 -8,000	-21%	-$83K	0.2%	126
2020 Q1	$359K	Buy	37,500 +1,500	+4%	+$18K	0.29%	107
2019 Q4	$518K	Buy	36,000 +2,500	+7%	+$36.4K	0.25%	115
2019 Q3	$504K	Buy	+33,500	New	+$467K	0.21%	130

Other funds holding OPNT

WSL

Western Standard LLC Los Angeles, California $190M AUM 40.88% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

NYLIM

New York Life Investment Management New York $11.8B AUM 23.45% 1-Year Est. Return

CSS LLC Chicago, Illinois $2.09B AUM 59.56% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

Ramius Advisors New York $95.2M AUM 7.33% 1-Year Est. Return

Perritt Capital Management's OPNT Position: Q4 2022 in Review

Perritt Capital Management sold out of Opiant Pharmaceuticals, Inc. Common Stock (OPNT) in Q4 2022, closing a stake of 30,500 shares — an estimated $328K sold.

Perritt Capital Management first reported a position in OPNT in Q3 2019 and held it in 13 quarters. The position peaked at $1.08M in Q4 2021. 37 funds tracked by Wall St. Rank hold OPNT as of Q4 2022.

Perritt Capital Management reported no remaining Opiant Pharmaceuticals, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Perritt Capital Management sold 30,500 Opiant Pharmaceuticals, Inc. Common Stock shares in Q4 2022, an estimated $328K.
Perritt Capital Management first reported a position in Opiant Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 13 quarters.
Perritt Capital Management's Opiant Pharmaceuticals, Inc. Common Stock position peaked at $1.08M in Q4 2021.
37 funds tracked by Wall St. Rank held Opiant Pharmaceuticals, Inc. Common Stock as of Q4 2022.

Based on Perritt Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.